You are here

AbbVie

AbbVie's Roche-rivaling blood cancer bispecific gets FDA priority review, triggering Genmab payday

Fierce Biotech

Mon, 11/21/22 - 10:12 am

bispecific antibodies

relapsed or refractory large B-cell lymphoma

Optum to add biosimilars to formulary to tackle the massive cost of Humira

Fierce Healthcare

Wed, 11/16/22 - 11:16 pm

AbbVie inks $54M settlement to resolve Namenda 'pay-for-delay' lawsuit

Fierce Pharma

Tue, 11/15/22 - 06:37 pm

Alzheimer's disease

Best Places to Work in Biopharma 2023 Report Reveals Most Sought-After Employers

BioSpace

Mon, 11/14/22 - 10:59 am

corporate culture

Moderna Therapeutics

AbbVie Touts Subgroup Data in Phase II Atrial Fibrillation Miss

BioSpace

Tue, 11/8/22 - 11:04 am

atrial fibrillation

clinicla trials

This Biopharma Offspring Is All Grown Up

Medical Devices and Diagnostics Industry

Tue, 11/8/22 - 12:02 pm

AbbVie Drops Autoimmune Candidate, Prioritizes Skyrizi and Rinvoq

BioSpace

Tue, 11/1/22 - 11:04 am

AbbVie puts up fight against Orilissa generics from Sandoz, Teva and others

Endpoints

Mon, 10/31/22 - 04:22 pm

Teva Pharmaceuticals

Systemic lupus erythematosus: major drug trials to watch in 2022 and 2023

Clinical Trials Arena

Mon, 10/31/22 - 10:37 am

clinical trials

systemic lupus erythematosus

Swedish Orphan Biovitrum

AbbVie sheds autoimmune disease drug in blow to partner Inventiva

Pharmaphorum

Mon, 10/31/22 - 10:21 am

autoimmune disease

AbbVie preps for an onslaught of Humira biosimilars in 2023, with Skyrizi and Rinvoq to fill the gap for now

Endpoints

Sun, 10/30/22 - 04:22 pm

AbbVie Gains Access to Pulmonary Fibrosis Antibody with $225M DJS Buy

BioSpace

Thu, 10/20/22 - 11:29 pm

pulmonary fibrosis

What Pharma Companies Can Expect From the Influx of Humira Biosimilars

Drug Channels

Fri, 10/14/22 - 10:15 am

BeiGene heaps more pressure on AbbVie, J&J with new Brukinsa head-to-head win over Imbruvica

Fierce Pharma

Wed, 10/12/22 - 11:00 am

The gloom deepens for biopharma stocks

EP Vantage

Mon, 10/10/22 - 06:54 pm

biopharma stocks

CRISPR Therapeutics

Intellia Therapeutics

Sarepta Therapeutics

BioSpace Layoff Tracker 2022: Cyclerion, OncoSec Implement Restructuring Initiatives

BioSpace

Fri, 10/7/22 - 10:45 am

Bristol Myers Squibb

Rubius Therapeutics

Finch Therapeutics

Q3 2022: Layoffs Continue, Alzheimer’s Soars and Accelerated Approvals Fall

BioSpace

Mon, 10/3/22 - 11:33 pm

Vesalius Therapeutics

Bristol Myers Squibb

Where Will AbbVie Be in 3 Years?

Motley Fool

Fri, 09/30/22 - 10:50 am

As lead drug flopped and AbbVie collab dissolved, cancer biotech resorts to buying rare disease company

Endpoints

Thu, 09/29/22 - 10:02 am

Idera Pharmaceuticals

AbbVie and BMS slash 360 jobs in California, the latest in a streak of biopharma layoffs

Fierce Pharma

Sun, 09/18/22 - 10:45 pm

Bristol Myers Squibb

Pages